Rao Raghu 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Jul 15, 2025
Insider Transaction Report
Form 4
Rao Raghu
DirectorInterim CEO
Transactions
- Award
Common Stock
2025-07-11+20,000→ 22,356 total
Footnotes (3)
- [F1]On July 11, 2025, the Reporting Person was granted 20,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on the earlier of (i) January 8, 2026, or (ii) the date of a "Change in Control" (as defined under the Issuer's 2020 Omnibus Equity Incentive Plan).
- [F2]Includes unvested restricted stock units.
- [F3]All amounts reflect the Issuer's 1:22 reverse stock split effective as of August 31, 2023 and 1:8 reverse stock split effective as of September 30, 2024.